Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.

CONCLUSION: In patients on hemodialysis, 24-week treatment with ferric citrate hydrate resulted in significant reduction in FGF23 and ERI independently of serum phosphate level.
PMID: 29874654 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - June 6, 2018 Category: Urology & Nephrology Authors: Maruyama N, Otsuki T, Yoshida Y, Nagura C, Kitai M, Shibahara N, Tomita H, Maruyama T, Abe M Tags: Am J Nephrol Source Type: research